| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 02/22/2011 | CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 02/17/2011 | US20110039827 Substituted hydroxamic acids and uses thereof |
| 02/16/2011 | EP2284166A1 Arylsulfonamides with analgetic activity |
| 02/16/2011 | CN201744187U Scraper shaft assembly for caprolactam jacketed crystallizer |
| 02/16/2011 | CN201744178U Caprolactam recovery unit |
| 02/16/2011 | CN1960727B Naphthalene derivatives useful as histamine-3-receptor ligands |
| 02/16/2011 | CN1850804B Optical-purity meptazinol orits salts, and preparing method |
| 02/16/2011 | CN101973939A Chiral nitrogen heterocyclic heptane compound and preparation method thereof |
| 02/16/2011 | CN101238106B Fluoro substituted 2-oxo azepan derivatives |
| 02/15/2011 | US7888345 Benzaepinones as sodium channel blockers |
| 02/10/2011 | WO2011016648A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/09/2011 | EP1644321B1 New benzamides as ppaty modulators |
| 02/09/2011 | CN101967107A Method of manufacturing benzoazepin compound or its salt |
| 02/08/2011 | CA2480940C Non-steroidal progesterone receptor modulators |
| 02/08/2011 | CA2459374C Photoactivable nitrogen bases |
| 02/03/2011 | WO2011012810A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same |
| 02/03/2011 | CA2767285A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same |
| 02/02/2011 | EP2279741A2 Caprolactams and their use as anti-inflammatory agents |
| 02/02/2011 | CN101962369A Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 02/02/2011 | CN101962361A Maleic acid Trimipramine compound and new preparation method thereof |
| 02/02/2011 | CN101415673B Process for the preparation of an N-alkyl lactam with improved colour quality |
| 02/01/2011 | US7879999 Method for the synthesis of exocyclic derivatives of cycloalkyl-hydrazines and exocyclic derivatives of heterocycloalkyl-hydrazines |
| 02/01/2011 | US7879842 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 02/01/2011 | US7879841 crystal structured 3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride, used for the treatment of angina pectoris, myocardial infarct, and congestive heart failure; bradycardial agents |
| 02/01/2011 | US7879834 Spiroindoline modulators of muscarinic receptors |
| 02/01/2011 | US7879826 N-methyl-D-aspartate (NMDA) receptor antagonists, such as Diethyl 3,3'-[({2-[8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl]ethyl}phosphoryl)bis(oxy)]dibenzoate, used for treating pain in a mammals; analgesics |
| 02/01/2011 | US7879825 N-methyl-D-aspartate (NMDA) receptor antagonists, such as 3-{2-[8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl]ethyl)-3-oxido-7-oxo-7-phenyl-2,4,6-trioxa-3-phosphahept-1-yl benzoate, used for treating pain ; analgesics |
| 02/01/2011 | CA2509554C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 01/27/2011 | WO2011010843A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/27/2011 | WO2010113179A3 Process for purifying eslicarbazepine acetate |
| 01/27/2011 | WO2009139001A3 An improved process for the preparation of oxcarbazepine |
| 01/27/2011 | US20110021488 New Compounds |
| 01/27/2011 | US20110021358 Use of sarmentine and its analogs for controlling plant pests |
| 01/26/2011 | EP2276742A1 Ivabradine hydrobromide |
| 01/26/2011 | EP1919874B1 Process for preparing benzazepine compounds or salts thereof |
| 01/26/2011 | CN101955457A General preparation method of optical-activity 3-aminopyrrolidine, 3-alkyl amino piperidine and derivatives thereof |
| 01/26/2011 | CN101274911B Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| 01/25/2011 | US7875605 1-Benzenesulfonyl-3-(4-methylpiperazin-1-ylmethyl)-5-nitro-1 H-indole; 1-[[5-Bromo-1-(2-Bromo-4-methoxybenzenesulfonyl)-indo1-3-yl]methyl][1,4]diazepane; useful for treating psychotic and neurodegenerative disorders e.g. schizophrenia, Alzheimer's disease, Parkinson's disease and Huntington's chorea |
| 01/25/2011 | CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/20/2011 | WO2011007247A1 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
| 01/20/2011 | US20110015182 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
| 01/20/2011 | US20110014186 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 01/20/2011 | CA2767987A1 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
| 01/19/2011 | CN101948431A Caprolactam sealed diphenylmethane diisocyanate monomer additive product and preparation method thereof |
| 01/18/2011 | US7872001 Gamma d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 01/13/2011 | WO2010096384A3 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands |
| 01/13/2011 | US20110009623 Selective growth of stable polymorphs |
| 01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 01/13/2011 | US20110009621 Supported transition metal complex and use thereof in catalysis |
| 01/12/2011 | CN1856313B Therapeutic compounds |
| 01/12/2011 | CN101945863A Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 01/12/2011 | CN101941964A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/12/2011 | CN101570511B Method for preparing mozavaptan |
| 01/11/2011 | US7867997 δ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 01/11/2011 | US7867996 a crystal stuctured form of 3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]-propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride, useful as bradycardial agents |
| 01/11/2011 | US7867995 βd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 01/11/2011 | US7867994 reacting 3-[2-(1,3-dioxolan-2-yl)ethyl]-7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, with 7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]-N-methylmethanamine hydrochloride, in the presence of hydrogen and palladium supported on carbon, to give ivabradine hydrochloride; bradycardial agents |
| 01/06/2011 | WO2011000915A1 Isoform-selective hcn blockers |
| 01/06/2011 | WO2010129057A3 Tetracycline compounds |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003795 Substituted Aromatic Carboxamide and Urea Derivatives as Vanilloid Receptor Ligands |
| 01/04/2011 | US7863443 3,5-dioxa-4-phospha-cyclohepta[2,1-a; 3,4-a']diphenyl-4-en)-10,11-dihydro-dibenzo[b,f]azepine use as a catalyst including an iridium complex for the production allylamine from allyl alcohol |
| 12/29/2010 | WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 12/29/2010 | CA2765678A1 Substituted hydroxamic acids and uses thereof |
| 12/28/2010 | US7858780 Intermediate to antiepileptic drugs |
| 12/28/2010 | US7858779 chlorocarbonylating, ammonolysis, and deprotecting; using triphosgene; without using corrosive reagents such as phosgene |
| 12/28/2010 | US7858778 Hydrolysis of the nitrile group of 5-cyano-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine with hydrogen peroxide, or a Group 1A or 2A perborate or persulfate, in alkaline ethanol or isopropanol and in the presence of microwaves |
| 12/28/2010 | US7858776 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein |
| 12/28/2010 | US7858613 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs |
| 12/23/2010 | US20100324025 Antibacterial Agents |
| 12/22/2010 | EP2264037A1 Vasopressin v1a antagonists |
| 12/22/2010 | EP1915345B1 Fluoro substituted 2-oxo azepan derivatives |
| 12/22/2010 | EP1781299B1 Anti-inflammatory agents |
| 12/22/2010 | CN101117326B Method for preparing aminocaprolactam by catalysis of nicotinic acid in ionic liquid |
| 12/21/2010 | US7855198 Benzamide derivative or salt thereof |
| 12/21/2010 | CA2580833C Method of preparing poly(adp-ribose) polymerases inhibitors |
| 12/21/2010 | CA2448896C Allylmercaptocaptopril compounds and uses thereof |
| 12/16/2010 | WO2010144873A1 Production of adipic acid and derivatives from carbohydrate-containing materials |
| 12/16/2010 | WO2010144862A2 Production of adipic acid and derivatives from carbohydrate-containing materials |
| 12/16/2010 | US20100317823 Production of Adipic Acid and Derivatives from Carbohydrate-Containing Materials |
| 12/16/2010 | US20100316731 Treatment of age-related macular degeneration |
| 12/16/2010 | CA2764116A1 Production of adipic acid and derivatives from carbohydrate-containing materials |
| 12/16/2010 | CA2763777A1 Production of adipic acid and derivatives from carbohydrate-containing materials |
| 12/15/2010 | EP2262030A2 Organic light emitting device |
| 12/15/2010 | EP2261215A1 Process for preparing benzazepine compounds or salts thereof |
| 12/14/2010 | CA2355939C Antihistaminic spiro compounds |
| 12/09/2010 | US20100311728 Manipulation of brain CDP-diacylglycerol and uses thereof |
| 12/09/2010 | US20100311727 Therapeutic amine-arylsulfonamide conjugate compounds |
| 12/08/2010 | CN101277937B Asymmetric catalytic reduction of oxcarbazepine |
| 12/07/2010 | CA2540248C Resolution of a narwedine amide derivative |
| 12/02/2010 | US20100305316 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| 12/02/2010 | US20100305100 Methods for treating hepatitis c |
| 12/02/2010 | US20100305099 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 12/01/2010 | EP2256104A1 Process for the preparation of alpha-aminosubstituted carboxylic acid amides |
| 12/01/2010 | EP1851196B1 Lactam production method |
| 11/30/2010 | US7842729 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections |
| 11/25/2010 | US20100298299 non-peptide derivatives as bradykinin b1 antagonists |
| 11/25/2010 | US20100298296 Oligomer-Tricyclic Conjugates |
| 11/24/2010 | EP2253315A1 Alkoxyphenylpropanoic acid derivatives |
| 11/24/2010 | CN101891681A Novel Beckmann rearrangement method for preparing caprolactam from cyclohexanone oxime |